CTLA4 and Autoimmunity: This indicates that in vivo suppression mediated by Treg cells through CTLA‐4 participates in the prevention of antitumor immune responses and, as described above with CTLA‐4 haploinsufficiency, of autoimmunity and/or immune dysregulation in the skin, the gut and in some endocrine organs.